ID #1093 Patient-derived diffuse midline glioma organoids model H3K27M-driven OPC stemness and guide personalized therapy

作者
Luyang Xie,Zhuang Jiang,Hang Zhou,Xiaoxue Zhu,Yibo Geng,Cheng Xu,Li Zhang
标识
DOI:10.1093/neuped/wuag026.491
摘要

Abstract H3K27 altered diffuse midline gliomas (DMGs) remain therapeutically intractable due to their anatomical inaccessibility, preserved blood-brain barrier and intrinsic treatment resistance. Progress in understanding disease mechanisms and developing effective therapies has been hindered by the low efficiency and limited fidelity of existing preclinical models. Here, we established a patient-derived diffuse midline glioma organoid system with high generation efficiency (54/59, 91.5%), encompassing all midline segments and representing the largest cohort reported to date. These organoids faithfully recapitulate the histopathological architecture, molecular landscapes, and microenvironmental features of their parental tumors. Integrated multi-omics analyses and functional assays revealed that H3K27M-mutant DMGs sustain oligodendrocyte precursor cell (OPC) stemness through dysregulation of ACTIVIN signaling. To overcome drug delivery barriers and therapeutically target stemness, we performed multi-level anti-stemness drug screening and identified a triple intrathecal therapy (TIT) regimen with selective efficacy against DMGs. TIT markedly suppressed OPC stemness and synergistically inhibited tumor growth in vitro and in vivo. Moreover, organoid-based avatar drug testing across distinct genetic backgrounds revealed differential genotype-phenotype associations between therapeutic responses. At equivalent concentrations, TIT demonstrated a stronger association with H3.3K27M mutation status and showed greater sensitivity in pontine DMG organoids, independent of TP53 mutation status. In contrast, ONC-201 exhibited higher efficacy in thalamic or midbrain DMG organoids and in tumors harboring concurrent ACVR1 mutations.In patients with DMG, organoid-guided personalized TIT or ONC-201 treatment achieved sustained clinical responses. Collectively, this study established a robust organoid platform for mechanistic interrogation and personalized therapy screening, and identified TIT as a promising translational strategy for H3K27M-mutant DMG.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
虚心灵煌完成签到,获得积分10
1秒前
237完成签到,获得积分10
1秒前
仄言完成签到,获得积分10
2秒前
渡边卯卯完成签到,获得积分10
2秒前
Hello的应助被liu采纳,获得10
2秒前
dashuaicai完成签到,获得积分20
2秒前
kkk发布了新的文献求助10
2秒前
2秒前
wang完成签到,获得积分10
2秒前
2秒前
Lucas的应助被咩了个咩采纳,获得10
3秒前
黑猫黑猫发布了新的文献求助10
3秒前
午凌二发布了新的文献求助30
3秒前
3秒前
4秒前
4秒前
无极微光的应助被enuiu采纳,获得20
4秒前
元灿霓发布了新的文献求助10
5秒前
5秒前
科研小白发布了新的文献求助10
6秒前
仄言发布了新的文献求助10
6秒前
6秒前
S11f完成签到,获得积分10
6秒前
7秒前
斯文败类的应助被活泼的筝采纳,获得30
7秒前
情怀的应助被dadadaniu采纳,获得10
7秒前
bgdw1219发布了新的文献求助20
7秒前
吖吖发布了新的文献求助10
7秒前
852的应助被麦季采纳,获得10
7秒前
shaco发布了新的文献求助10
7秒前
7秒前
英勇秋完成签到,获得积分10
8秒前
星辰大海的应助被CT采纳,获得10
8秒前
萍05完成签到,获得积分10
8秒前
百里幻竹发布了新的文献求助10
9秒前
zdy完成签到,获得积分20
9秒前
9秒前
9秒前
夏木发布了新的文献求助10
9秒前
9秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
Analyses de reconnaissances de dettes passées devant les échevins d'Ypres (1249-1291) 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8161749
求助须知:如何正确求助?哪些是违规求助? 9556240
关于积分的说明 21733360
捐赠科研通 7751657
什么是DOI,文献DOI怎么找? 3427566
关于科研通互助平台的介绍 2552632
邀请新用户注册赠送积分活动 2472047